Nose bleeds associated with use of risperidone.
Harrison-Woolrych
Mira
M
Intensive Medicines Monitoring Programme, New Zealand Pharmacovigilance Centre, Department of Preventive and Social Medicine, University of Otago, New Zealand. Mira.harrisonwoolrych@stonebow.otago.ac.nz
Clark
David W J
DW
D000328:Adult; D004844:Epistaxis / Q000139:chemically induced*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D018967:Risperidone / Q000009:adverse effects*; D012702:Serotonin Antagonists / Q000009:adverse effects*
D012702:Serotonin Antagonists; D018967:Risperidone